Cladribine Tablets Mode of Action, Learning from the Pandemic: A Narrative Review
Abstract Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system, characterized by chronic, inflammatory, demyelinating, and neurodegenerative processes. MS management relies on disease-modifying drugs that suppress/modulate the immune system. Cladribine tablets (CladT) h...
Main Authors: | Federico Carlini, Valeria Lusi, Caterina Rizzi, Francesco Assogna, Alice Laroni |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2023-07-01
|
Series: | Neurology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40120-023-00520-6 |
Similar Items
-
Experience with cladribine tablets for highly active multiple sclerosis in everyday clinical practice
by: S. V. Petrov, et al.
Published: (2020-08-01) -
Treatment of Multiple Sclerosis with Cladribine Tablets: Literature Review and the Guidance of the Lithuanian Association of Neurologists
by: R. Kizlaitienė, et al.
Published: (2024-03-01) -
Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis
by: Jerome de Seze, et al.
Published: (2024-04-01) -
Experience with cladribine tablets for highly active multiple sclerosis in real clinical practice
by: S. V. Petrov, et al.
Published: (2022-02-01) -
Effect of Cladribine on Neuronal Apoptosis: New Insight of In Vitro Study in Multiple Sclerosis Therapy
by: Maddalena Ruggieri, et al.
Published: (2020-08-01)